Bio-Techne to Present at Major Investor Conferences
Exciting news is on the horizon for Bio-Techne Corporation (NASDAQ: TECH) as it reveals its participation in key investor conferences. This is a fantastic opportunity for stakeholders to gain insights into the company’s innovations and future directions.
List of Upcoming Conferences
Bio-Techne is scheduled to present at the following notable investor gatherings:
Annual Evercore Healthcare Conference
Taking place on December 2, 2025, this annual event promises deep insights into healthcare advancements, with Bio-Techne slated to present at 8:20 AM EST.
Citi's Global Healthcare Conference
On December 3, 2025, at 3:15 PM EST, Bio-Techne will engage with investors and analysts during this globally recognized event focused on healthcare innovation.
Nasdaq Investor Conference
Wrapping up the series of presentations, Bio-Techne will be featured at the 53rd Annual Nasdaq Investor Conference on December 9, 2025, at 9:30 AM GMT, where it will discuss its impactful contributions to life sciences.
Webcast Availability
For those interested in following along, a live webcast of the presentations will be readily accessible through the investor relations section of Bio-Techne’s website.
About Bio-Techne Corporation
Bio-Techne Corporation, listed under NASDAQ: TECH, is a leading innovator in the life sciences field. The company is dedicated to providing advanced tools and bioactive reagents for both research and clinical diagnostics. Bio-Techne plays a vital role in enhancing scientific understanding of biological processes and disease progression. Its extensive range of products significantly supports drug discovery initiatives and clinical testing accuracy. In the recent fiscal year, Bio-Techne achieved over $1.2 billion in net sales and employs around 3,100 individuals globally, reflecting its significant impact in the life sciences sector.
Explore More
For further details regarding Bio-Techne and its extensive array of offerings, individuals can visit the official Bio-Techne website. The company actively shares its updates and insights through various social media platforms, including LinkedIn, X, and YouTube, where followers can learn more about its groundbreaking work in life sciences.
Contact Information
For inquiries, please reach out to David Clair, who serves as the Vice President of Investor Relations and Corporate Development at Bio-Techne. His dedication contributes to enhancing investor communications and engagement.
Frequently Asked Questions
What is Bio-Techne Corporation known for?
Bio-Techne is recognized for its innovative tools and bioactive reagents that support research and clinical diagnostics in life sciences.
When will Bio-Techne present at the investor conferences?
Bio-Techne is scheduled to present on December 2, 3, and 9 across different healthcare conferences in 2025.
How can I access the presentations?
The presentations will be available via a live webcast on Bio-Techne's Investor Relations website.
What is the financial performance of Bio-Techne?
In the last fiscal year, Bio-Techne generated over $1.2 billion in net sales, a testament to its industry standing.
Who should I contact for more information about Bio-Techne?
David Clair, the Vice President of Investor Relations & Corporate Development, is the contact for further inquiries about Bio-Techne.